XML 25 R15.htm IDEA: XBRL DOCUMENT

Equity Based Compensation	9 Months Ended
Equity Based Compensation	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Equity Based Compensation	Equity Based Compensation Equity compensation expense was $31 million and $40 million in the first nine months of 2022 and 2021, respectively. In the first quarter of 2022, the Company granted 258,327 stock appreciation rights at $106.53 weighted average exercise price per share, 78,687 performance contingent shares and 219,553 restricted stock units to employees. Additionally, non-employee directors were granted a total of 17,937 shares of common stock. As of September 30, 2022, 1,652,736 share awards at a weighted average strike price per share of $107.03 were vested and exercisable, with a remaining weighted average exercise period of 4.2 years. As of September 30, 2022, the total compensation cost of non-vested awards not yet recognized in the condensed consolidated financial statements was $31 million. It is estimated that these costs will vest over a weighted average period of 0.7 years.